GL1X · GenesisL1 explorer

Research workbench

A novel domain in human exog converts apoptotic endonuclease to DNA- repair enzyme

Analyse A novel domain in human exog converts apoptotic endonuclease to DNA- repair… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5T3V
Type
protein
Length
599 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclease exog, mitochondrial
EC
3.1.30.-
UniProt
Q9Y2C4
Ligands
MN, SO4
Pockets
6 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclease exog, mitochondrial (EC 3.1.30.-)protein29934% helix, 25% strandQ9Y2C4
BNuclease exog, mitochondrial (EC 3.1.30.-)protein30035% helix, 24% strandQ9Y2C4

Ligands and binding sites

  • MN · Manganese (II) ion · metal · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13740.840.9356empty
24050.590.7535MN, SO4
32530.530.7624MN, SO4
4640.300.7417empty
5640.270.7317empty

Interfaces

1 interface between chains.

  • A–B · 2600 Ų buried · 35 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • Q9Y2C4 · AlphaFold monomer V2.0 prediction for nuclease exog, mitochondrial (Q9Y2C4) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.